Source: Thinkstock
IPO ETF manager Renaissance Capital reported that the average return this year was 16%, close to the 10-year mean, but well short of 2013’s average return of 41%. Some 40% of 2014 IPOs priced below the expected range.
These were the top 10 IPOs by deal size and return:
- Alibaba, $22 billion, 60.3%
- Citizens Financial Group Inc. (NYSE: CFG), $3.01 billion, 14.2%
- Synchrony Financial (NYSE: SYF), $2.875 billion, 25.7%
- Ally Financial Inc. (NYSE: ALLY), $2.375 billion, -11.4%
- Paramount Group Inc. (NYSE: PGRE), $2.293 billion, 4.7%
- Santander Consumer USA Holdings Inc. (NYSE: SC), $1.8 billion, -22.8%
- JD.com Inc. (NASDAQ: JD), $1.78 billion, 23.7%
- IMS Health Holdings Inc. (NYSE: IMS), $1.3 billion, 26.5%
- Markit Ltd. (NASDAQ: MRKT), $1.283 billion, 4%
- Grupo Aval Acciones y Valores S.A. (NYSE: AVAL), $1.1 billion, -25.3%
There were 100 health care IPOs launched in 2014 that raised a total of $8.7 billion. Technology companies posted the second largest share with 55 IPOs for a total value of $32.3 billion (including Alibaba of course), and there were 36 financial IPOs that raised a total of $18.6 billion.
The poorest performing IPO sectors for the year were utilities, where one IPO posted a negative 13% return and energy where 30 IPOs posted an average negative 13% return. The 100 health care IPOs posted an average return of 31.7%, driven by biotech companies. Tech companies produced an average return of 55% in 2013, but that dropped to 14% in 2014.
Looking ahead, Renaissance Capital noted that 347 companies made initial IPO filings in 2014, up 36% year-over-year, and that the current pipeline includes 107 companies seeking to raise $19.3 billion. The IPO ETF management firm also said that its watch list has increased to 255 companies, of which some 80% are tech companies, including familiar names like Uber, Airbnb, Spotify and Dropbox.
ALSO READ: 5 Cheapest Dow Stocks for 2015
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
